Related Experiment Video
Updated: Jun 22, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Remyelination capacity of the MS brain decreases with disease chronicity
T Goldschmidt1, J Antel, F B König
1Department of Neuropathology, University Medical Center, Göttingen, Germany.
Objective:
To analyze and compare the extent of remyelination in lesions from patients with multiple sclerosis (MS) who have a short (early MS lesions) or a long (chronic MS lesions) disease duration and to determine the influence of anatomic localization on the extent of remyelination. In early MS lesions, remyelination has been described as a relatively frequent event, in contrast to chronic MS lesions, where remyelination is absent or limited to the lesion border in the majority of lesions. However, no studies have been published that have quantified and compared the extent of remyelination in early and chronic MS lesions.
Methods:
We analyzed the occurrence of remyelination in 52 biopsies from 51 patients (early MS) and in 174 lesions from 36 autopsy cases (chronic MS) by immunohistochemistry for myelin proteins, and correlated our findings with anatomic localization, sex, age, and disease duration.
Results:
Significantly more lesions were remyelinated in early than in chronic MS (80.7% vs 60%). In chronic MS, subcortical lesions showed more extensive remyelination than periventricular lesions. The majority of cerebellar lesions were completely demyelinated.
Conclusion:
In summary, our data demonstrate that remyelination is a frequent event in early multiple sclerosis lesions. Furthermore, the anatomic localization of a lesion might influence the extent of remyelination.
Insights
Remyelination is frequent in early multiple sclerosis (MS) lesions but less common in chronic MS. Lesion location also influences remyelination extent, with subcortical lesions showing more repair than periventricular ones.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
- Remyelination, the process of restoring myelin sheaths around axons, is a key factor in recovery and neuroprotection in MS.
- The extent and frequency of remyelination in early versus chronic MS lesions remain incompletely understood.
Purpose of the Study:
- To quantitatively compare the extent of remyelination in early and chronic MS lesions.
- To investigate the impact of lesion anatomic localization on remyelination in MS.
- To provide a detailed analysis of remyelination patterns across different disease durations and locations.
Main Methods:
- Immunohistochemical analysis of myelin proteins in biopsy samples from early MS lesions and autopsy cases of chronic MS lesions.
- Quantification of remyelination occurrence and extent.
- Correlation of remyelination with lesion location, patient sex, age, and disease duration.
Main Results:
- A significantly higher proportion of early MS lesions (80.7%) showed remyelination compared to chronic MS lesions (60%).
- In chronic MS, subcortical lesions exhibited more extensive remyelination than periventricular lesions.
- Cerebellar lesions in chronic MS were predominantly completely demyelinated.
Conclusions:
- Remyelination is a common occurrence in the early stages of multiple sclerosis.
- The anatomical site of a demyelinating lesion influences the capacity for remyelination.
- These findings highlight the dynamic nature of remyelination in MS and its dependence on disease stage and location.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Neurogenesis and Regeneration of Nervous Tissue
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Secondary Spinal Cord Injury llI: Pathophysiology

